Recall fallout: FDA puts execs on notice

By Parija Kavilanz , senior writer


NEW YORK (CNNMoney.com) -- High-profile recalls are shining a spotlight on food and drug product safety lapses, and prompting the government to consider bringing criminal charges against corporate executives.

The Food and Drug Administration is serious about identifying and potentially prosecuting senior individuals at companies that have issued a number of recalls due to manufacturing violations, said people familiar with the agency's thinking.

FDA officials have dropped public hints lately. Eric Blumberg, FDA's deputy chief counsel for litigation, told an industry gathering in April that the agency would go after executives at companies that seem to be flouting the FDA's rules.

"Very soon, and I have no one particular in mind, some corporate executive is going to be the first in a long line ... So it's going to happen. Do what you can and do the right thing before we find out about it," Blumberg said.

And FDA Commissioner Margaret Hamburg wrote to Sen. Chuck Grassley, R-Iowa, in March to say that the agency intends to consider "the appropriate use of misdemeanor prosecutions, a valuable enforcement tool, to hold responsible corporate officials accountable."

The FDA'a Office of Criminal Investigations is investigating the successive recalls of Tylenol and other over-the-counter drugs made by Johnson & Johnson's (JNJ, Fortune 500) McNeil Consumer Healthcare unit.

Sharpening up dull knives. Over the past thirty years, the FDA's enforcement arm has atrophied.

The FDA hasn't been aggressively punishing companies for manufacturing violations that spurred product recalls, said Lewis Grossman, professor of law at American University.

Now industry insiders say the FDA seems intent on reviving a tough law that has been dormant since the '80's. Its aim: To send a strong signal to companies.

The FDA gets its authority from the "Park Doctrine," which allows it to seek criminal convictions for violations of the federal Food, Drug and Cosmetic Act against executives, even if they're unaware of specific manufacturing violations but are in a position of authority to prevent or correct the problems.

"The FDA has generally avoided resorting to court to enforce their actions," said Grossman, an expert in food and drug law. That wasn't always the case. According to Grossman, the agency brought more than 600 criminal prosecutions against companies in 1939, but that the number plummeted to about 16 in 1989.

The number of criminal prosecutions climbed again in 1991 after the OCI was formed, but those were mainly for fraud and not based on food and drug manufacturing violations, he said.

Food and drug recalls have climbed in recent years.

The FDA reported more than 1,742 drug recalls in 2009, skyrocketing from 426 in 2008, according to the Gold Sheet, a trade publication on drug quality that analyzes FDA data. The fast pace is continuing in 2010 with drug recalls totaling 296 from January through June.

Recalls of food products are also increasing. In 2006 there were more than 200 recalls. That number jumped to about 305 in 2008 and more than 500 in 2009, according to the FDA.

So far there have been 684 food product recalls in 2010.

Grossman said there seems to be a perception at the agency that "working it out with the company and the company doing a voluntary recall is not enough."

"No one is really getting into trouble," Grossman said. At the same time, the number of citations for violations and warning letters that the FDA is issuing companies is going up.

David Rosen, who worked at the FDA for 14 years and is now with the law firm Foley & Lardner, agreed.

"The FDA is developing a tougher compliance attitude because companies are ignoring warnings from the FDA. It appears the agency does want to send a clearer message to people now," said Rosen, who advises major pharmaceutical companies on FDA regulations and compliance.

Punishments for a misdemeanor conviction can range from a $1,000 fine to a year in jail, while a felony conviction can result in a $10,000 fine or three years in prison, Grossman said.

Although the FDA has yet to bring any criminal charges against high-ranking executives, experts say there are a lot of sleepless nights right now in the industry. There's a lot a company can do for its executives, but one thing it can't do is serve their jail time. To top of page

Frontline troops push for solar energy
The U.S. Marines are testing renewable energy technologies like solar to reduce costs and casualties associated with fossil fuels. Play
25 Best Places to find rich singles
Looking for Mr. or Ms. Moneybags? Hunt down the perfect mate in these wealthy cities, which are brimming with unattached professionals. More
Fun festivals: Twins to mustard to pirates!
You'll see double in Twinsburg, Ohio, and Ketchup lovers should beware in Middleton, WI. Here's some of the best and strangest town festivals. Play
Index Last Change % Change
Dow 17,778.15 421.28 2.43%
Nasdaq 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
Treasuries 2.20 0.06 2.61%
Data as of 7:23am ET
Company Price Change % Change
Bank of America Corp... 17.53 0.27 1.56%
Apple Inc 112.65 3.24 2.96%
Oracle Corp 45.35 4.19 10.18%
General Electric Co 25.14 0.71 2.91%
Microsoft Corp 47.52 1.78 3.89%
Data as of Dec 18

Sections

German chemicals company BASF has dropped a planned asset swap with Russia's Gazprom as Western sanctions bite. More

Investors beware: These 5 global crises are likely to rattle the stock market and world economy. More

Portland's mayor says the city will create new rules, eventually allowing Uber to operate there. More

With two recent IPOs and a digitally-inclined audience of entrepreneurs, non-traditional financing could finally get its big break. More

Payday lenders are spending millions of dollars in Washington in an attempt to get powerful politicians on their side as a government crackdown on the industry heats up. More

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.